Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations]
Introduction Sexual dysfunctions are common yet underreported side effects of antipsychotics for schizophrenia, affecting 30-80% of treated individuals. These side effects can severely impact social interactions and treatment adherence for individuals with schizophrenia, but comprehensive comparativ...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2025-06-01
|
| Series: | F1000Research |
| Subjects: | |
| Online Access: | https://f1000research.com/articles/13-973/v3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850114044779823104 |
|---|---|
| author | Wulf Peter Hansen Spyridon Siafis Orestis Efthimiou Shimeng Dong Johannes Schneider-Thoma David D. Kim Stefan Leucht Karl Heinz Möhrmann Elfriede Scheuring |
| author_facet | Wulf Peter Hansen Spyridon Siafis Orestis Efthimiou Shimeng Dong Johannes Schneider-Thoma David D. Kim Stefan Leucht Karl Heinz Möhrmann Elfriede Scheuring |
| author_sort | Wulf Peter Hansen |
| collection | DOAJ |
| description | Introduction Sexual dysfunctions are common yet underreported side effects of antipsychotics for schizophrenia, affecting 30-80% of treated individuals. These side effects can severely impact social interactions and treatment adherence for individuals with schizophrenia, but comprehensive comparative evidence assessing the risk profiles of different antipsychotics is lacking. This study aims to address this gap using network meta-analysis that integrates data from both randomized-controlled trials (RCTs) and non-randomized studies (NRS). Protocol This systematic review will include both RCTs and NRS focusing on participants with schizophrenia or schizophrenia-like psychoses, without restrictions on symptoms, gender, ethnicity, age, or setting. For interventions, all second-generation antipsychotics will be included. The primary outcome will be the occurrence of at least one sexual adverse event of any kind. Secondary outcomes will be the occurrence of any sexual adverse event evaluated in men and women separately, and any adverse event related to the three phases of sexual response cycle separately: desire (e.g. libido, sexual thoughts), arousal (e.g. erection, lubrication) and orgasm (e.g. ejaculation, anorgasmia), and any adverse effect related to breast dysfunction and menstruation irregularities. Study selection and data extraction will be performed independently by two reviewers. The Cochrane Risk of Bias tool 1 and ROBINS-I will be employed to evaluate the risk of bias for RCTs and NRS, respectively. Single-arm meta-analysis of proportions will synthesize the average frequency of sexual adverse events in treated participants. Pairwise and network meta-analysis of RCTs and NRS will be used to evaluate comparative tolerability. Subgroup and sensitivity analyses will explore possible heterogeneity in results and validate the findings’ robustness. The quality of the evidence will be evaluated using GRADE. Discussion This study will provide vital insights into the sexual side effects of antipsychotics by combining evidence from clinical trials and real-world practice, facilitating better decision-making in choosing the optimal antipsychotic for individuals. |
| format | Article |
| id | doaj-art-c41a8f3ed70c4cee936df4683bcc8cf0 |
| institution | OA Journals |
| issn | 2046-1402 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | F1000 Research Ltd |
| record_format | Article |
| series | F1000Research |
| spelling | doaj-art-c41a8f3ed70c4cee936df4683bcc8cf02025-08-20T02:36:59ZengF1000 Research LtdF1000Research2046-14022025-06-011310.12688/f1000research.154742.3183803Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations]Wulf Peter Hansen0Spyridon Siafis1https://orcid.org/0000-0001-8264-2039Orestis Efthimiou2Shimeng Dong3Johannes Schneider-Thoma4https://orcid.org/0000-0002-3448-9532David D. Kim5Stefan Leucht6https://orcid.org/0000-0002-4934-4352Karl Heinz Möhrmann7Elfriede Scheuring8BASTA-Bündnis für psychisch erkrankte Menschen, Munich, GermanyTUM School of Medicine and Health, Klinikum rechts der Isar, Department of Psychiatry and Psychotherapy, Technical University of Munich, Munich, GermanyInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandTUM School of Medicine and Health, Klinikum rechts der Isar, Department of Psychiatry and Psychotherapy, Technical University of Munich, Munich, GermanyTUM School of Medicine and Health, Klinikum rechts der Isar, Department of Psychiatry and Psychotherapy, Technical University of Munich, Munich, GermanyPartner Site München/Augsburg, German Center for Mental Health (DZPG), Munich, GermanyTUM School of Medicine and Health, Klinikum rechts der Isar, Department of Psychiatry and Psychotherapy, Technical University of Munich, Munich, GermanyLandesverband Bayern der Angehörigen psychisch erkrankter Menschen e.V., Munich, GermanyBASTA-Bündnis für psychisch erkrankte Menschen, Munich, GermanyIntroduction Sexual dysfunctions are common yet underreported side effects of antipsychotics for schizophrenia, affecting 30-80% of treated individuals. These side effects can severely impact social interactions and treatment adherence for individuals with schizophrenia, but comprehensive comparative evidence assessing the risk profiles of different antipsychotics is lacking. This study aims to address this gap using network meta-analysis that integrates data from both randomized-controlled trials (RCTs) and non-randomized studies (NRS). Protocol This systematic review will include both RCTs and NRS focusing on participants with schizophrenia or schizophrenia-like psychoses, without restrictions on symptoms, gender, ethnicity, age, or setting. For interventions, all second-generation antipsychotics will be included. The primary outcome will be the occurrence of at least one sexual adverse event of any kind. Secondary outcomes will be the occurrence of any sexual adverse event evaluated in men and women separately, and any adverse event related to the three phases of sexual response cycle separately: desire (e.g. libido, sexual thoughts), arousal (e.g. erection, lubrication) and orgasm (e.g. ejaculation, anorgasmia), and any adverse effect related to breast dysfunction and menstruation irregularities. Study selection and data extraction will be performed independently by two reviewers. The Cochrane Risk of Bias tool 1 and ROBINS-I will be employed to evaluate the risk of bias for RCTs and NRS, respectively. Single-arm meta-analysis of proportions will synthesize the average frequency of sexual adverse events in treated participants. Pairwise and network meta-analysis of RCTs and NRS will be used to evaluate comparative tolerability. Subgroup and sensitivity analyses will explore possible heterogeneity in results and validate the findings’ robustness. The quality of the evidence will be evaluated using GRADE. Discussion This study will provide vital insights into the sexual side effects of antipsychotics by combining evidence from clinical trials and real-world practice, facilitating better decision-making in choosing the optimal antipsychotic for individuals.https://f1000research.com/articles/13-973/v3Sexual side effects antipsychotics schizophrenia meta-analysiseng |
| spellingShingle | Wulf Peter Hansen Spyridon Siafis Orestis Efthimiou Shimeng Dong Johannes Schneider-Thoma David D. Kim Stefan Leucht Karl Heinz Möhrmann Elfriede Scheuring Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations] F1000Research Sexual side effects antipsychotics schizophrenia meta-analysis eng |
| title | Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations] |
| title_full | Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations] |
| title_fullStr | Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations] |
| title_full_unstemmed | Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations] |
| title_short | Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studies [version 3; peer review: 2 approved, 1 approved with reservations] |
| title_sort | sexual dysfunction and other prolactin related side effects of antipsychotic drugs in schizophrenia protocol for a systematic review with single arm pairwise and network meta analyses of randomized controlled trials and non randomized studies version 3 peer review 2 approved 1 approved with reservations |
| topic | Sexual side effects antipsychotics schizophrenia meta-analysis eng |
| url | https://f1000research.com/articles/13-973/v3 |
| work_keys_str_mv | AT wulfpeterhansen sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv AT spyridonsiafis sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv AT orestisefthimiou sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv AT shimengdong sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv AT johannesschneiderthoma sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv AT daviddkim sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv AT stefanleucht sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv AT karlheinzmohrmann sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv AT elfriedescheuring sexualdysfunctionandotherprolactinrelatedsideeffectsofantipsychoticdrugsinschizophreniaprotocolforasystematicreviewwithsinglearmpairwiseandnetworkmetaanalysesofrandomizedcontrolledtrialsandnonrandomizedstudiesversion3peerreview2approved1approvedwithreserv |